Wegovy, with the active ingredient semaglutide, is an injection used for chronic weight management. Semaglutide is also available under the brand name Ozempic, where it is FDA-approved for diabetes and often prescribed off-label for weight loss.

However, Wegovy is a formulation of semaglutide that is specifically approved for weight loss and is FDA-approved for the treatment of obesity.

Incorporating medications such as Wegovy into weight loss efforts and the management of obesity is important in treating obesity as a chronic health condition that can lead to a wide range of deteriorating health outcomes, both physically and mentally.

By incorporating Wegovy for weight loss in nondiabetics as part of a comprehensive medical weight management plan in collaboration with the specialists at PrimeHealth Urgent Care, patients can expect to achieve considerable weight loss and drastically improve health outcomes.

When it comes to determining suitability for Wegovy, this is a decision that is made on a case-by-case basis as part of a broader medical weight management plan.

This plan will contain several health and lifestyle changes to help patients progress toward their target weight. Suitability for medication such as Wegovy will be considered under certain circumstances on a case-by-case basis.

While this is an individual decision made collaboratively between providers at PrimeHealth Urgent Care and patients, there are general requirements to qualify for Wegovy for medical weight management. Individuals who are classified as obese with a BMI of 30 or higher can qualify for the use of Wegovy.

Additionally, individuals who are overweight with a BMI of 27 or higher and are affected by a weight-related health condition such as hypertension, obstructive sleep apnea, dyslipidemia, and more may be deemed eligible for the use of the medication to aid in their weight loss efforts.

How much weight an individual can lose in three months with Wegovy varies on a case-by-case basis. Wegovy will typically be administered at a low dosage and scaled up as the patient becomes used to the medication.

Some patients will start to experience the appetite-suppressing and weight-loss effects almost immediately, while others may not experience any notable changes until their dosage scales up.

Typically, they’ll begin at a dosage of 0.25 mg for the first month of usage of Wegovy. During the second month, this will be increased up to 0.5 mg, and for the third month, the dosage can be increased up to 1 mg per week.

They’re intended for long-term usage to help patients steadily lose a significant quantity of weight safely. How much weight will be lost in the first two months varies, with some individuals experiencing a weight reduction of five to 10% of their overall body weight during even the first three months of the administration of the medication, while others may not achieve the more noticeable effects until the dosage is scaled up after the beginning three-month period.

Adherence to diet and exercise will also influence how quickly an individual loses weight with Wegovy. Additionally, providers at PrimeHealth Urgent Care will monitor patient progress and work with them towards their comprehensive weight loss goals, adjusting Wegovy dosages as necessary based on patient response to the medication.

Wegovy is a safe and effective weight loss method that helps obese and overweight individuals lose considerable amounts of weight. By regulating the body’s appetite and diminishing the number of calories consumed, Wegovy assists with long-term weight loss.

Being obese is associated with a wide range of adverse health effects, including heart disease and much more. While there are some side effects associated with medications such as Wegovy, including nausea, diarrhea, vomiting, and more, these typically subside as the individual becomes used to the medication and are fleeting compared to the much more severe consequences associated with being overweight.

Modest weight loss can drastically improve health outcomes for obese and overweight individuals. Significant weight loss achievable with Wegovy can be life-changing when incorporated as part of a comprehensive medical weight management plan.

Wegovy is an injectable weight-loss medical treatment used to treat adults who are obese or have extra weight due to weight-related disorders. Wegovy for medical weight loss is available at PrimeHealth Urgent Care. For more information, contact us or request an appointment online. We are conveniently located at 5660 Fishhawk Crossing Blvd, Lithia, FL 33547. We serve patients from Lithia FL, Balm FL, Keysville FL, Hopewell FL, and surrounding areas.